Bundelkhand Online Journal

Meconium Aspiration Syndrome Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032)| Key Companies – Fervent Pharmaceuticals, Astellas Pharmaceuticals, Bayer, Pfi

 Breaking News
  • No posts were found

Meconium Aspiration Syndrome Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032)| Key Companies – Fervent Pharmaceuticals, Astellas Pharmaceuticals, Bayer, Pfi

May 23
22:50 2023
Meconium Aspiration Syndrome Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032)| Key Companies - Fervent Pharmaceuticals, Astellas Pharmaceuticals, Bayer, Pfi
DelveInsight Business Research LLP
DelveInsight’s “Meconium Aspiration Syndrome Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Meconium Aspiration Syndrome, historical and forecasted epidemiology as well as the Meconium Aspiration Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s “Meconium Aspiration Syndrome Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Meconium Aspiration Syndrome, historical and forecasted epidemiology as well as the Meconium Aspiration Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Meconium Aspiration Syndrome Overview

Meconium aspiration syndrome occurs when a newborn breathes a mixture of meconium and amniotic fluid into the lungs around the time of delivery. Meconium aspiration syndrome, a leading cause of severe illness and death in the newborn, occurs in about 5 percent to 10 percent of births.

Meconium Aspiration Syndrome Epidemiology Insights

In the industrialized world, meconium in the amniotic fluid can be detected in 8-25% of all births after 34 weeks gestation. Historically, approximately 10% of newborns born through meconium-stained amniotic fluid developed meconium aspiration syndrome.

 Higher risk of MASINT was noted at advanced gestation, with 34% of cases born beyond 40 weeks, compared with 16% of infants without MAS. Fetal distress requiring obstetric intervention was noted in 51% of cases, and 42% were delivered by cesarean section.

Click here to learn more about the Meconium Aspiration Syndrome Market Landscape

The Report Covers the Meconium Aspiration Syndrome Epidemiology Segmented by:

  • Total Meconium Aspiration Syndrome incident cases 

  • Total Meconium Aspiration Syndrome prevalent cases 

  • Total Meconium Aspiration Syndrome treatment cases 

  • Total Meconium Aspiration Syndrome diagnostic cases 

Meconium Aspiration Syndrome Market Outlook 

The Meconium Aspiration Syndrome market outlook of the report helps to build a detailed comprehension of the historical, current and forecasted Meconium Aspiration Syndrome market trends by analyzing the impact of current Meconium Aspiration Syndrome therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Meconium Aspiration Syndrome market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Meconium Aspiration Syndrome market data are presented with relevant tables and graphs to give a clear view of the market at first sight.According to DelveInsight, the Meconium Aspiration Syndrome market in 7MM is expected to witness a major change in the study period 2019-2032.

 Key Companies Working in the Meconium Aspiration Syndrome Market

  • Fervent Pharmaceuticals 

  • Astellas Pharmaceuticals 

  • Bayer 

  • Pfizer 

  • Novartis 

  • Takeda 

  • GlaxsoSmith Kline 

And many others 

 Meconium Aspiration Syndrome Therapies Covered and Analyzed in the Report:

  •  FP101 

  •  Fezolinetant

  •  Erenumab

  •  MF101

  •  Cyproterone Acetate

  •  PD-0299685

  •  Gabapentin

And many others 

 

Learn more about the Key Companies and Emerging Therapies in the Meconium Aspiration Syndrome Market

 

Table of Contents 

  1. Key Insights 

  2. Meconium Aspiration Syndrome  Introduction 

  3. Executive Summary of Meconium Aspiration Syndrome       

  4. Disease Background and Overview

  5. Epidemiology and patient population

  6. Meconium Aspiration Syndrome Emerging Therapies

  7. Meconium Aspiration Syndrome Market Outlook

  8. Market Access and Reimbursement of Therapies

  9. Market Drivers 

  10. Market Barriers 

  11. Appendix

  12. Report Methodology

  13. DelveInsight Capabilities

  14. Disclaimer

Learn about the detailed offerings of the report @ Meconium Aspiration Syndrome Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services